NeuroKaire Secures $10 Million to Advance Precision Medicine for Mental Health
Pioneering Approach Brings Insights from Neuronal Response to Identifying Personalized Drug Efficacy for Depression KEARNY, N.J., Dec. 17, 2024 /PRNewswire/ — NeuroKaire, a pioneering biotechnology company specializing in precision medicine in psychiatry and neurology, has successfully secured $10 million in funding…